Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introduction
The Market Access Framework for MPT Development and Introduction is intended to serve as a resource to inform product
development and investment decision-making that is focused specifically on market access components of MPT development and introduction—in other words, activities that are critical to ensuring that MPTs in development are not only efficacious in clinical trials, but also desired, acceptable, and accessible to women and adolescent girls once introduced and commercially available.
This framework document was prepared by Laura Dellplain (IMPT), Bethany Young Holt (IMPT), Anke Hemmerling (UCSF and IMPT Scientific Advisor), Joseph Romano (NWJ Group and IMPT Scientific Advisor), Ariane van der Straten (RTI International and IMPT Scientific Advisor), and Jim Turpin (NIAID). This work could not have been completed without the valuable insights and contributions from IMPT partner organization representatives. The IMPT Secretariat would like to thank Amy Lin and Janine Hum (USAID) in particular for their guidance and engagement during this process.
April 2019
Click for full info +Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introduction
 | April 2019 |
- HIV
- STI / STD
- Unintended Pregnancy
- MPTs
- MPTs
- Product Development
- Product Trials
Full Info:
Resource Type:
Citation:
Dellplain, L., Young Holt, B., Hemmerling, A., Romano, J., van der Straten, A., & Turpin, J. (2016, January 21). Initiative for Multipurpose Prevention Technologies.
Authors:
Dellplain, L., Young Holt, B., Hemmerling, A., Romano, J., van der Straten, A., & Turpin, J.
Health Risks(s):
- HIV
- STI / STD
- Unintended Pregnancy
Product type(s):
- MPTs
Topic(s):
- MPTs
- Development
- Trials
- Social
URL of resource:
https://theimpt.org/wp/wp-content/uploads/2022/01/Market-Access-Framework-for-MPT-Development.pdf